{"id":"W4220672160","doi":"10.1016/s1470-2045(22)00122-x","title":"Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial","year":2022,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Clovis Oncology","keywords":"Ovarian cancer; Chemotherapy; Mutation; Cancer; Phases of clinical research; Poly ADP ribose polymerase; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001572238,0.001629649,0.003023827,0.0004441079,0.0003122804,0.001072563,0.001141536,0.001734669,0.008580633],"category_scores_gemma":[0.001902383,0.0005939917,0.002243723,0.000488608,0.001199794,0.001281098,0.0004422158,0.004355559,0.001290664],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008244857,"about_ca_system_score_gemma":0.0006999216,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001037925,"about_ca_topic_score_gemma":0.002366924,"domain_scores_codex":[0.9993654,0.0003695792,0.00002541109,0.0001045764,0.00003561087,0.00009952678],"domain_scores_gemma":[0.9991682,0.0003226953,0.0001441868,0.00006795044,0.00004076586,0.0002562748],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9694219,0.002757625,0.000424568,0.0007289898,0.001246409,0.00003553362,0.00004434118,0.0005555642,0.001353499,0.0001750811,0.0012162,0.02204035],"study_design_scores_gemma":[0.9443165,0.05153726,0.001371111,0.00005462168,0.0005421708,0.00005392974,0.00002809206,0.000620003,0.0002430731,0.0002805853,0.0009333984,0.00001935108],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9721661,0.01498396,0.0009437955,0.001709793,0.001310368,0.002032456,0.001488023,0.0003124667,0.005052928],"genre_scores_gemma":[0.9847618,0.004451014,0.001291298,0.001485074,0.0004837427,0.001464655,0.001426589,0.00004047143,0.004595306],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008580633,"threshold_uncertainty_score":0.02870506,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07535907588749029,"score_gpt":0.4198910124240871,"score_spread":0.3445319365365968,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}